HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-13 receptor-alpha2: a novel target for cancer therapy.

AuthorsBharat H Joshi, Raj K Puri
JournalImmunotherapy (Immunotherapy) Vol. 1 Issue 3 Pg. 321-7 (May 2009) ISSN: 1750-7448 [Electronic] England
PMID20635949 (Publication Type: Editorial)
Chemical References
  • Antineoplastic Agents
  • Cytokines
  • Interleukin-13 Receptor alpha2 Subunit
  • STAT6 Transcription Factor
Topics
  • Animals
  • Antineoplastic Agents (immunology, metabolism)
  • Clinical Trials as Topic
  • Cytokines (immunology, metabolism)
  • Cytotoxicity, Immunologic
  • Humans
  • Immunotherapy
  • Interleukin-13 Receptor alpha2 Subunit (genetics, immunology, metabolism)
  • Neoplasms (drug therapy, immunology)
  • STAT6 Transcription Factor (metabolism)
  • Signal Transduction (drug effects, immunology)
  • Th1-Th2 Balance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: